LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 89 of 166
Next
>>
>
2201 to 2225 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	PD173074	3.33	uM	LJP6	72	hr	1657	6371	5383	1.1849	1.2102
BT-20	PD173074	10	uM	LJP6	72	hr	1657	5503	5383	1.0229	1.0271
BT-20	Crizotinib	0.04	uM	LJP5	72	hr	1657	4615	5588	0.8261	0.7934
BT-20	Crizotinib	0.12	uM	LJP5	72	hr	1657	5034	5588	0.9007	0.8840
BT-20	Crizotinib	0.37	uM	LJP5	72	hr	1657	4808	5588	0.8603	0.8351
BT-20	Crizotinib	1.11	uM	LJP5	72	hr	1657	4527	5588	0.8101	0.7735
BT-20	Crizotinib	3.33	uM	LJP5	72	hr	1657	3569	5588	0.6389	0.5488
BT-20	Crizotinib	10	uM	LJP5	72	hr	1657	1646	5588	0.2946	-0.0041
BT-20	BMS345541	0.04	uM	LJP6	72	hr	1657	5435	5383	1.0104	1.0127
BT-20	BMS345541	0.12	uM	LJP6	72	hr	1657	5506	5383	1.0235	1.0279
BT-20	BMS345541	0.37	uM	LJP6	72	hr	1657	5520	5383	1.0256	1.0302
BT-20	BMS345541	1.11	uM	LJP6	72	hr	1657	4882	5383	0.9072	0.8879
BT-20	BMS345541	3.33	uM	LJP6	72	hr	1657	4482	5383	0.8337	0.7971
BT-20	BMS345541	10	uM	LJP6	72	hr	1657	1686	5383	0.3135	0.0101
BT-20	KIN001-043	0.04	uM	LJP6	72	hr	1657	5295	5383	0.9838	0.9810
BT-20	KIN001-043	0.12	uM	LJP6	72	hr	1657	5203	5383	0.9661	0.9591
BT-20	KIN001-043	0.37	uM	LJP6	72	hr	1657	5458	5383	1.0146	1.0177
BT-20	KIN001-043	1.11	uM	LJP6	72	hr	1657	5417	5383	1.0066	1.0079
BT-20	KIN001-043	3.33	uM	LJP6	72	hr	1657	5475	5383	1.0170	1.0199
BT-20	KIN001-043	10	uM	LJP6	72	hr	1657	3221	5383	0.5978	0.4766
BT-20	Saracatinib	0.04	uM	LJP6	72	hr	1657	5648	5383	1.0488	1.0562
BT-20	Saracatinib	0.12	uM	LJP6	72	hr	1657	5246	5383	0.9750	0.9706
BT-20	Saracatinib	0.37	uM	LJP6	72	hr	1657	4894	5383	0.9091	0.8904
BT-20	Saracatinib	1.11	uM	LJP6	72	hr	1657	4346	5383	0.8059	0.7591
BT-20	Saracatinib	3.33	uM	LJP6	72	hr	1657	3616	5383	0.6712	0.5806

|<
<<
Previous
Page 89 of 166
Next
>>
>
2201 to 2225 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)